“This is a result of the difficulty in creating an appropriate controlled, double-blind testing situation. Acupuncture is an invasive treatment, so it’s hard to design an effective placebo control group for a study the way standard double blinding practices are used in trials for new drugs. Acupuncture is also a process, not a pill. A process has a lot of variables, including the influence of the acupuncturist, which is a major factor. Blinding both the acupuncturist and the patient as to the treatment being given is a challenge.” Read More on Huffington Post